<DOC>
	<DOCNO>NCT02764853</DOCNO>
	<brief_summary>Striving Towards Empowerment Medication Adherence ( STEP-AD ) research study aim develop intervention Black woman live HIV address psychosocial factor ( i.e . abuse/trauma history , racial discrimination , HIV stigma/discrimination , prescribe traditional gender role ) associate medication nonadherence poor HIV outcome ( e.g . viral load , CD4 ) , unaddressed exist intervention .</brief_summary>
	<brief_title>Striving Towards EmPowerment Medication Adherence ( STEP-AD )</brief_title>
	<detailed_description>Among Black woman HIV U.S , generally low rate adherence ART likely due relevant psychosocial contextual factor face Black woman HIV , history physical , sexual , emotional abuse , post traumatic stress , racial discrimination , contextual variable relate traditional gender role ; associate bad HIV outcome . Despite need , currently evidenced-based psychosocial intervention Black woman HIV address contextual factor improve adherence HIV self-care . A psychosocial intervention include content reduce effect trauma discrimination increase resilient cop strategy gender empowerment may culturally appropriate , therefore effective , improve quality life increase treatment adherence Black woman live HIV/AIDS . Striving Towards Empowerment Medication Adherence ( STEP-AD ) research study aim develop intervention Black woman live HIV address psychosocial factor ( i.e . abuse/trauma history , racial discrimination , HIV stigma/discrimination , prescribe traditional gender role ) associate medication nonadherence poor HIV outcome ( e.g . viral load , CD4 ) , unaddressed exist intervention . Individual , in-depth qualitative interview ( n=30 ) conduct Black woman HIV community stakeholders gather information perceive acceptability inform development manualized intervention integrate treatment improve ART adherence address trauma symptom , racial discrimination , HIV discrimination , gender relate stressor experience Black woman HIV . This information use develop result intervention . An open pilot trial ( n=5 ) result intervention conduct ( December 2015 August 2016 ) order initially assess feasibility study procedure intervention delivery , acceptability , potential clinically significant improvement ART adherence hypothesize psychosocial mediator . A pilot randomize control trial ( RCT ) compare newly develop intervention ( N=25 ) enhance treatment usual control ( N=25 ) ART adherence ( primary outcome ) viral load ( secondary outcome ) 6 month ( baseline , 10 weekly treatment visit [ approximately 3 month ] , 6 month follow-up ) begin enrol participant August 2016 .</detailed_description>
	<criteria>1 . HIVpositive 2 . Identify Black and/or African American 3 . Age 18 old 4 . Biologically female 5 . English speak 6 . Prescribed ART medication least last two month 7 . Low ART adherence ( &lt; 80 % ) detectable viral load within past six month 8 . History abuse/trauma ( e.g . sexual , physical , and/or emotional abuse , experience traumatic event ) 9 . Capable complete fully understand informed consent process study procedures 1 . Significant mental health diagnosis require treatment ( e.g. , unstable bipolar disorder ; psychotic disorder ) 2 . Inability ( e.g. , due cognitive psychiatric difficulty ) unwillingness provide inform consent 3 . Recent ( past 6 month ) behavioral treatment ART adherence trauma</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>Black</keyword>
	<keyword>African American</keyword>
	<keyword>Women</keyword>
	<keyword>Cognitive Behavioral Therapy</keyword>
	<keyword>Racism</keyword>
	<keyword>Stigma</keyword>
	<keyword>Discrimination</keyword>
	<keyword>Gender relate stressor</keyword>
	<keyword>Resilience</keyword>
	<keyword>Behavioral Medicine</keyword>
</DOC>